Posts Tagged 'False Claims Act'

Teva Announces Department of Justice Investigation Into Potential False Claims Act Violations

In an annual report filed with the Securities and Exchange Commission, Teva Pharmaceutical Industries announced that the Department of Justice subpoenaed information relating to two of the company’s drugs. Copaxone, a drug to treat multiple sclerosis, is Teva’s top-selling drug. It is an injectable drug that the FDA approved for reducing the frequency of relapses, although there are claims that it may also reduce the progression of the disability. Azilect is used for ...

continue reading...